Summary
How BRL maps according to Revere
| Sector Level | Count |
|---|---|
Industries
|
1 |
Sectors
|
2 |
Subsectors
|
23 |
Product/Service Groups
|
253 |
Specific product example for BRL
| Product Hierarchy |
|---|
Healthcare
|
Biopharmaceuticals
|
Allergies
|
Dermatology
|
Antihistamines
|
Company Highlights:
Market Cap.
|
7,331.754 |
Current Shares Outstnd.
|
109.4 |
| Contact Name | Carol A. Cox |
| Contact Phone | (201)9303300 |
| City, State | Woodcliff Lake, NJ |
| Dividends Per Common Share | 0.00 |
| Dividend Yield | 0.00 |
SI %SHOUT
|
1.61 |
IH % Shares Outst.
|
77.94% |
| Number of Employees | 8,900 |
| Revenue Per Employee | 332,145.9 |
| Book Value Per Share | 18.91 |
| 5 Year CAGR in Revenues % | 17.25 |
| 5 Year CAGR in Earnings % | 37.99 |
Asset Turnover
|
0.15 |
| Fiscal Year End | 12/31/2008 |
| Next Reporting Period | Dec, 2008 |
Business Description:
Chart:
| Last Price | 66.99 |
| Price Chg. | 0.00 |
| Price Chg. % | 0.00% |
| Open Price | 66.99 |
| High Price | 67.34 |
| Low Price | 66.45 |
| 52w High Price | 68.35 |
| 52w Low Price | 37.40 |
| Volume | 5,226,878 |
| 30d Avg. Volume | 2,775,918 |
Products
| Products Manufactured/Services Performed Details |
|---|
Healthcare
|
Biopharmaceuticals
|
Allergies
|
Dermatology
|
Antihistamines
Products:
|
Antihistamines/Antiserotonins
Products:
|
Ophthalmology
|
Antihistamines/Antiserotonins
Products:
|
Non-Steroidal Anti-Inflammatory Drugs (NSAID)
|
Non-Specific Cyclooxygenase Inhibitors (COX Inhibitors)
Products:
|
Systemic
|
Anaphylactic Shock
|
Adjunctive Treatments
|
Antihistamines/Antiserotonins
Products:
|
Upper Respiratory
|
Antihistamines
Products:
|
Antihistamines/Antiserotonins
Products:
|
Antihistamines/Decongestants
Products:
|
Steroidal Anti-Inflammatory Drugs (SAID)
Products:
|
Cardiovascular System
|
Heart Disorders
|
Angina
|
Beta Adrenergic Receptor Blocking Agents (Beta Blockers)
Products:
|
Arrhythmia
|
Beta Adrenergic Receptor Blocking Agents (Beta Blockers)
Products:
|
Sodium Channel Blocking Agents
Products:
|
Sodium Channel Blocking Agents/Potassium Channel Blocking Agents
Products:
|
Heart Failure (HF)
|
Complications
|
Edema
|
Loop Diuretic Agents
Products:
|
Potassium Sparing Diuretic Agents/Thiazide Diuretic Agents
Products:
|
Thiazide Diuretic Agents
Products:
|
Myocardial Infarction (MI)
|
Beta Adrenergic Receptor Blocking Agents (Beta Blockers)
Products:
|
Free Fatty Acid Inhibitors
Products:
|
HMG CoA Reductase Inhibitors (Statins)
Products:
|
Vascular Disorders
|
Aneurysms
|
Hemorrhage
|
Calcium Channel Blocking Agents
Products:
|
Atherosclerosis
|
Free Fatty Acid Inhibitors
Products:
|
HMG CoA Reductase Inhibitors (Statins)
Products:
|
Deep Vein Thrombosis (DVT)
|
Anticoagulating Agents (Anticoagulants)
|
Thrombin Inhibitors
Products:
|
Hypertension
|
Alpha Adrenergic Receptor Blocking Agents (Alpha Blockers)
Products:
|
Beta Adrenergic Receptor Blocking Agents (Beta Blockers)
Products:
|
Beta Receptor Blocking Agents (Beta Blockers)/Thiazide Diuretic Agents
Products:
|
Loop Diuretic Agents
Products:
|
Potassium Sparing Diuretic Agents/Thiazide Diuretic Agents
Products:
|
Thiazide Diuretic Agents
Products:
|
Vasodilatory Agents
Products:
|
Peripheral Vascular Disease
|
Blood Viscosity Reducing Agents
Products:
|
Free Fatty Acid Inhibitors/HMG CoA Reductase Inhibitors (Statins)
Products:
|
Thromboembolism
|
Anticoagulating Agents (Anticoagulants)
|
Platelet Aggregation Inhibitors
|
Phosphodiesterase Inhibitors
Products:
|
Thrombin Inhibitors
Products:
|
Tremors
|
Beta Adrenergic Receptor Blocking Agents (Beta Blockers)
Products:
|
Dermatology
|
Acne
|
Vulgaris
|
Antibacterial Agents
|
Macrolides
Products:
|
Tetracyclines
Products:
|
Retinoids/Vitamin A Analogs
Products:
|
Lesion/Scaling Disorders
|
Chronic Urticaria
|
Antihistamines
Products:
|
Pruritus
|
Antihistamines
Products:
|
Psoriasis
|
Dihydrofolate Reductase Inhibitors
Products:
|
Immunosuppressants
Products:
|
Digestive System
|
Gastrointestinal Tract Disorders
|
Gastroduodenal Disorders
|
Peptic Ulcers
|
Duodenal
|
H2 Receptor Antagonists
Products:
|
Proton Pump Inhibitors
Products:
|
Gastric
|
H2 Receptor Antagonists
Products:
|
Zollinger-Ellison Syndrome
|
Proton Pump Inhibitors
Products:
|
Gastroesophageal Disorders
|
Acid Indigestion/Heartburn
|
H2 Receptor Antagonists
Products:
|
Erosive Esophagitis
|
Proton Pump Inhibitors
Products:
|
Gastroesophageal Reflux Disease (GERD)
|
Dopamine Receptor Blocking Agents
Products:
|
H2 Receptor Antagonists
Products:
|
Proton Pump Inhibitors
Products:
|
Gastroparesis
|
Dopamine Receptor Blocking Agents
Products:
|
Nausea/Vomiting
|
Antihistamines
Products:
|
Dopamine Receptor Blocking Agents
Products:
|
Serotonin Receptor Antagonists
Products:
|
Intestinal Disorders
|
Intestinal Intubation
|
Dopamine Receptor Blocking Agents
Products:
|
Liver Disorders
|
Cirrhosis
|
Complications
|
Edema
|
Loop Diuretic Agents
Products:
|
Potassium Sparing Diuretic Agents/Thiazide Diuretic Agents
Products:
|
Endocrinology/Metabolism
|
Adrenal Gland Disorders
|
Adrenocortical Insufficiency
|
Synthetic Adrenocortical Steroids
Products:
|
Diabetes
|
Induced Complications
|
Central Diabetes Insipidus
|
Antidiuretic Agents
Products:
|
Non-Insulin Dependent Diabetes Mellitus (NIDDM)/Type 2 Diabetes
|
Biguanides
Products:
|
Biguanides/Insulin Stimulating Agents
Products:
|
Insulin Stimulating Agents (Sulfonylureas)
Products:
|
General Hormone Treatments
|
Estrogens
Products:
|
Prednisolones
Products:
|
Intermediary Metabolism Disorders
|
Gout
|
Gouty Arthritis
|
Urate Resorption Inhibitors
Products:
|
Hyperuricemia
|
Urate Resorption Inhibitors
Products:
|
Hypercholesterolemia
|
Free Fatty Acid Inhibitors
Products:
|
Free Fatty Acid Inhibitors/HMG CoA Reductase Inhibitors (Statins)
Products:
|
HMG CoA Reductase Inhibitors (Statins)
Products:
|
Hyperlipidemia
|
Free Fatty Acid Inhibitors
Products:
|
Free Fatty Acid Inhibitors/HMG CoA Reductase Inhibitors (Statins)
Products:
|
HMG CoA Reductase Inhibitors (Statins)
Products:
|
Parathyroid Gland Disorders
|
Hyperparathyroidism (HPT)
|
Calcimimetic Agents
Products:
|
Vitamin D Analogs
Products:
|
Pituitary Gland Disorders
|
Hyperprolactenemia
|
Dopamine Receptor Agonists
Products:
|
Reproductive Disorders
|
Amenorrhea
|
Progestins
Products:
|
Menopause
|
Estrogens
Products:
|
Estrogens/Progestins
Products:
|
Progestins
Products:
|
Hematology
|
Hemophilia
|
Hemophilia A
|
Antidiuretic Agents
Products:
|
Red Blood Cell (RBC) Disorders
|
Anemia
|
Folic Acid Derivatives
Products:
|
Serum Factor Disorders
|
Hypercalcemia
|
Osteoclast Bone Resorption Inhibitors
Products:
|
Hypercholesterolemia
|
Free Fatty Acid Inhibitors
Products:
|
Free Fatty Acid Inhibitors/HMG CoA Reductase Inhibitors (Statins)
Products:
|
HMG CoA Reductase Inhibitors (Statins)
Products:
|
Hyperlipidemia
|
Free Fatty Acid Inhibitors/HMG CoA Reductase Inhibitors (Statins)
Products:
|
HMG CoA Reductase Inhibitors (Statins)
Products:
|
Hyperuricemia
|
Urate Resorption Inhibitors
Products:
|
Hypokalemia
|
Potassium Sparing Diuretic Agents/Thiazide Diuretic Agents
Products:
|
Thrombocyte (Platelet) Disorders
|
Thrombocythemia
|
Megakaryocyte Maturation Inhibitors
Products:
|
Immunology
|
Autoimmune Disorders
|
Arthritis
|
Rheumatoid Arthritis (RA)
|
Analgesics
|
Non-Steroidal Anti-Inflammatory Drugs (NSAID)
|
Non-Specific Cyclooxygenase Inhibitors (COX Inhibitors)
Products:
|
Disease Modifying Anti-Rheumatic Drugs (DMARD)
|
Dihydrofolate Reductase Inhibitors
Products:
|
Pyrimidine Synthesis Inhibitors
Products:
|
Immunotherapy
|
Immunosuppressants
Products:
|
Psoriasis
|
Dihydrofolate Reductase Inhibitors
Products:
|
Immunosuppressants
Products:
|
Immune Deficiency Disorders
|
Hereditary Angioedema
|
Gonadotropin Inhibitors
Products:
|
Human Immunodeficiency Virus (HIV)/Acquired Immune Deficiency Syndrome (AIDS)
|
Nucleoside Reverse Transcriptase Inhibitors (NRTI)
Products:
|
Infectious Diseases
|
Bacterial
|
Antibacterial Agents
|
Broad Spectrum
|
Antibiotics
|
Macrolides
Products:
|
Nitroimidazoles
Products:
|
Quinolones/Fluoroquinolones
Products:
|
Tetracyclines
Products:
|
Narrow Spectrum
|
Otolaryngology (Ear/Nose/Throat)
|
Otitis Media
|
Macrolides/Sulfonamides
Products:
|
Respiratory System
|
Pneumonia
|
Quinolones/Fluoroquinolones
Products:
|
Respiratory Tract Infections
|
Quinolones/Fluoroquinolones
Products:
|
Tuberculosis
|
Antitubercular Agents
Products:
|
Systemic
|
Leprosy
|
Erythema Nodosum Leprosum (ENL)
|
Immunomodulatory Agents
Products:
|
Urology
|
Prostatitis
|
Quinolones/Fluoroquinolones
Products:
|
Urinary Tract Infections (UTI)
|
Antibacterial Agents (Antibiotics)
|
Quinolones/Fluoroquinolones
Products:
|
Mycological (Fungal)
|
Antifungal Agents
|
Broad Spectrum
|
Azoles
|
Imidazoles
Products:
|
Narrow Spectrum
|
Dermatology
|
Candidiasis
|
Polyene Macrolide Antibiotics
Products:
|
Onychomycosis (Nail)
|
Amine Derivatives
|
Allyl
Products:
|
Digestive System
|
Mucous
|
Candidiasis
|
Polyene Macrolide Antibiotics
Products:
|
Nervous System
|
Cryptococcal Meningitis
|
Triazoles
Products:
|
Otolaryngology (Ear/Nose/Throat)
|
Esophageal Candidiasis
|
Triazoles
Products:
|
Oropharyngeal Candidiasis
|
Azoles
|
Triazoles
Products:
|
Polyene Macrolide Antibiotics
Products:
|
Urology
|
Vaginal Candidiasis
|
Azoles
|
Triazoles
Products:
|
Protozoal
|
Antiprotozoal Agents
|
Broad Spectrum
|
Nitroimidazoles
Products:
|
Narrow Spectrum
|
Malaria
|
Aminoquinolines
Products:
|
Viral
|
RNA Viruses
|
Retrovirus
|
Human Immunodeficiency Virus (HIV)/Acquired Immune Deficiency Syndrome (AIDS)
|
Nucleoside Reverse Transcriptase Inhibitors (NRTI)
Products:
|
Vaccines
|
Viral
|
Single Target
|
Adenoviruses
Products:
|
Musculoskeletal System
|
Skeletal Disorders
|
Bone Disorders
|
Osteoporosis
|
Hormonal Treatments
|
Estrogens
Products:
|
Estrogens/Progestins
Products:
|
Osteoclast Bone Resorption Inhibitors
Products:
|
Paget`s Disease
|
Osteoclast Bone Resorption Inhibitors
Products:
|
Joint Disorders
|
Ankylosing Spondylitis
|
Non-Steroidal Anti-Inflammatory Drugs (NSAID)
|
Non-Specific Cyclooxygenase Inhibitors (COX Inhibitors)
Products:
|
Gouty Arthritis
|
Urate Resorption Inhibitors
Products:
|
Osteoarthritis (OA)
|
Non-Steroidal Anti-Inflammatory Drugs (NSAID)
|
Non-Specific Cyclooxygenase Inhibitors (COX Inhibitors)
Products:
|
Rheumatoid Arthritis (RA)
|
Analgesics
|
Non-Steroidal Anti-Inflammatory Drugs (NSAID)
|
Non-Specific Cyclooxygenase Inhibitors (COX Inhibitors)
Products:
|
Disease Modifying Anti-Rheumatic Drugs (DMARD)
|
Dihydrofolate Reductase Inhibitors
Products:
|
Pyrimidine Synthesis Inhibitors
Products:
|
Immunotherapy
|
Immunosuppressants
Products:
|
Neurology
|
Neurological Disorders
|
Alzheimer`s Disease
|
Acetylcholinesterase Inhibitors/Nicotinic Receptor Modulators
Products:
|
N-Methyl-D-Aspartate (NMDA) Receptor Antagonists
Products:
|
Epilepsy
|
Partial Seizures
|
Complex
|
Adjunctive Therapy
|
Sodium Channel Blocking Agents/Gamma-Aminobutyric Acid (GABA) Receptor Agonists
Products:
|
Monotherapy
|
Sodium Channel Blocking Agents/Gamma-Aminobutyric Acid (GABA) Receptor Agonists
Products:
|
Simple
|
Adjunctive Therapy
|
Sodium Channel Blocking Agents/Gamma-Aminobutyric Acid (GABA) Receptor Agonists
Products:
|
Monotherapy
|
Sodium Channel Blocking Agents/Gamma-Aminobutyric Acid (GABA) Receptor Agonists
Products:
|
Primary Generalized Seizures
|
Absence (Petit Mal)
|
Adjunctive Therapy
|
Gamma-Aminobutyric Acid (GABA) Reuptake Inhibitors
Products:
|
Monotherapy
|
Calcium Channel Blocking Agents
Products:
|
Gamma-Aminobutyric Acid (GABA) Reuptake Inhibitors
Products:
|
Akinetic Pattern
|
Adjunctive Therapy
|
Gamma-Aminobutyric Acid (GABA) Reuptake Inhibitors
Products:
|
Monotherapy
|
Gamma-Aminobutyric Acid (GABA) Reuptake Inhibitors
Products:
|
Myoclonic
|
Adjunctive Therapy
|
Gamma-Aminobutyric Acid (GABA) Reuptake Inhibitors
Products:
|
Monotherapy
|
Gamma-Aminobutyric Acid (GABA) Reuptake Inhibitors
Products:
|
Tonic-Clonic (Grand Mal)
|
Sodium Channel Blocking Agents/Gamma-Aminobutyric Acid (GABA) Receptor Agonists
Products:
|
Headaches
|
Vascular (Migraine)
|
Prophylactic Treatments
|
Beta Adrenergic Receptor Blocking Agents (Beta Blockers)
Products:
|
Neuromuscular Disorders
|
Myasthenia Gravis (MG)
|
Cholinesterase Inhibitors
Products:
|
Parkinson`s Disease (PD)
|
Adjunctive Treatments
|
Cholinergic Receptor Blocking Agents
Products:
|
Monotherapy
|
Dopamine Receptor Agonists
Products:
|
Psychiatric Disorders
|
Anxiety
|
Generalized Anxiety Disorder (GAD)
|
Antihistamines
Products:
|
Dopamine Receptor Blocking Agents
Products:
|
Gamma-Aminobutyric Acid (GABA) Receptor Agonists
Products:
|
Selective Norepinephrine Reuptake Inhibitors (SNRI)
Products:
|
Obsessive Compulsive Disorder (OCD)
|
Selective Serotonin Reuptake Inhibitors (SSRI)
Products:
|
Panic Disorder
|
Gamma-Aminobutyric Acid (GABA) Receptor Agonists
Products:
|
Selective Serotonin Reuptake Inhibitors (SSRI)
Products:
|
Post-Traumatic Stress Disorder (PTSD)
|
Selective Serotonin Reuptake Inhibitors (SSRI)
Products:
|
Social Anxiety Disorder (SAD)
|
Selective Norepinephrine Reuptake Inhibitors (SNRI)
Products:
|
Selective Serotonin Reuptake Inhibitors (SSRI)
Products:
|
Childhood/Adolescent Disorders
|
Attention Deficit Disorder (ADD)/Attention Deficit Hyperactivity Disorder (ADHD)
|
Dopamine Receptor Blocking Agents
Products:
|
Sympathomimetic Agents
Products:
|
Enuresis (Bedwetting)
|
Antidiuretic Agents
Products:
|
Eating Disorders
|
Bulimia
|
Selective Serotonin Reuptake Inhibitors (SSRI)
Products:
|
Mood Disorders
|
Bipolar Disorders (Manic Depressive Disorders)
|
Lithium-Based Agents
Products:
|
Monoaminergic Antagonists
Products:
|
Depression
|
Selective Norepinephrine Reuptake Inhibitors (SNRI)
Products:
|
Selective Serotonin Reuptake Inhibitors (SSRI)
Products:
|
Tetracyclic Compounds
Products:
|
Tricyclic Compounds
Products:
|
Premenstrual Dysphoric Disorders
|
Selective Serotonin Reuptake Inhibitors (SSRI)
Products:
|
Schizophrenia
|
Dopamine Receptor Blocking Agents
Products:
|
Monoaminergic Antagonists
Products:
|
Sleep Disorders
|
Insomnia
|
Gamma-Aminobutyric Acid (GABA) Receptor Agonists
Products:
|
Narcolepsy
|
Alpha Adrenergic Receptor Agonists
Products:
|
Sympathomimetic Agents
Products:
|
Obstetrics/Gynecology
|
Child Birth/Pregnancy
|
Prevention (Contraception)
|
Contraceptives (Birth Control)
|
Estrogens
Products:
|
Estrogens/Progestins
Products:
|
Progestins
Products:
|
Female Genital Disorders
|
Endometriosis
|
Gonadotropin Inhibitors
Products:
|
Ovarian
|
Hypogonadism
|
Hormonal Treatments
|
Estrogens
Products:
|
Vulvovaginal
|
Atrophy
|
Hormonal Treatments
|
Estrogens
Products:
|
Estrogens/Progestins
Products:
|
Oncology
|
Breast Cancer
|
Localized
|
Antimetabolite Agents
|
Dihydrofolate Reductase Inhibitors
Products:
|
Estrogen Receptor Blocking Agents
Products:
|
Progestins
Products:
|
Metastatic
|
Antimicrotubule Agents
Products:
|
Estrogen Receptor Blocking Agents
Products:
|
Dermatology
|
Malignant Melanoma
|
Ribonucleotide Reductase Inhibitors
Products:
|
Digestive System
|
Colon Cancer/Colorectal Cancer
|
Metastatic
|
Alkylating Agents
|
Platinum-Based Agents
Products:
|
Topoisomerase I Inhibitors
Products:
|
Palliative Agents
|
Folic Acid Derivatives
Products:
|
Endocrinology
|
Parathyroid Gland
|
Palliative Agents
|
Calcimimetic Agents
Products:
|
Head/Neck Cancer
|
Localized
|
Antimetabolite Agents
|
Dihydrofolate Reductase Inhibitors
Products:
|
Ribonucleotide Reductase Inhibitors
Products:
|
Hematology
|
Leukemia (White Blood Cell Cancer)
|
Lymphoid
|
Acute
|
Lymphocytic
|
Antimetabolite Agents
|
Dihydrofolate Reductase Inhibitors
Products:
|
Meningeal
|
Antimetabolite Agents
|
Dihydrofolate Reductase Inhibitors
Products:
|
Myeloid
|
Acute
|
Promyelocytic (APL)
|
Retinoids/Vitamin A Analogs
Products:
|
Chronic
|
Myelogenous (CML)
|
Ribonucleotide Reductase Inhibitors
Products:
|
Lymphoma (Lymphatic Cancer)
|
Non-Hodgkin`s Lymphoma (NHL)
|
Antimetabolite Agents
|
Dihydrofolate Reductase Inhibitors
Products:
|
Multiple Myeloma (Plasma Cell Cancer)
|
Immunomodulatory Agents
Products:
|
Musculoskeletal System
|
Bone Cancer
|
Osteosarcoma
|
Palliative Agents
|
Folic Acid Derivatives
Products:
|
Metastatic
|
Osteolytic Bone Metastases
|
Osteoclast Bone Resorption Inhibitors
Products:
|
Urology
|
Endometrial Cancer
|
Localized
|
Progestins
Products:
|
Kidney Cancer (Renal Cell Carcinoma)
|
Metastatic
|
Hormonal Treatments
|
Progestins
Products:
|
Ovarian Cancer
|
Adenocarcinoma
|
Alkylating Agents
|
Platinum-Based Agents
Products:
|
Ribonucleotide Reductase Inhibitors
Products:
|
Palliative Agents
|
Alkylating Agents
|
Platinum-Based Agents
Products:
|
Prostate Cancer
|
Localized
|
Androgen Receptor Blockers
Products:
|
Metastatic
|
Androgen Receptor Blockers
Products:
|
Ophthalmology
|
Degenerative Disorders
|
Glaucoma
|
Carbonic Anhydrase Inhibitors
Products:
|
Irritation/Inflammation
|
Non-Steroidal Anti-Inflammatory Drugs (NSAID)
|
Non-Specific Cyclooxygenase Inhibitors (COX Inhibitors)
Products:
|
Pain Management
|
Anesthesia
|
General (Systemic)
|
Adjunctive
|
Gamma-Aminobutyric Acid (GABA) Receptor Agonists
Products:
|
Opioids
Products:
|
Narcotics
|
Analgesics/Opioids
Products:
|
Opioid Analgesics
Products:
|
Opioids
Products:
|
Non-Narcotics
|
Non-Steroidal Anti-Inflammatory Drugs (NSAID)
|
Non-Specific Cyclooxygenase Inhibitors (COX Inhibitors)
Products:
|
Skeletal Muscle Relaxing Agents
Products:
|
Respiratory System
|
Lower Respiratory Tract Disorders (Lung Disorders)
|
Asthma
|
Prophylactic Treatments
|
Phosphodiesterase Inhibitors (PDE Inhibitors)
Products:
|
Bronchitis
|
Prophylactic Treatments
|
Phosphodiesterase Inhibitors (PDE Inhibitors)
Products:
|
Emphysema
|
Prophylactic Treatments
|
Phosphodiesterase Inhibitors (PDE Inhibitors)
Products:
|
Upper Respiratory Tract Disorders
|
Coughs/Colds
|
Antihistamines
Products:
|
Antihistamines/Antiserotonins
Products:
|
Antitussives
Products:
|
Steroidal Anti-Inflammatory Drugs (SAID)
Products:
|
Surgery
|
Cardiovascular System
|
Thrombosis
|
Thrombin Inhibitors
Products:
|
General
|
Complications
|
Nausea/Vomiting
|
Serotonin Receptor Antagonists
Products:
|
Musculoskeletal System
|
Deep Vein Thrombosis (DVT)
|
Anticoagulating Agents (Anticoagulants)
|
Thrombin Inhibitors
Products:
|
Ophthalmology
|
Ocular Inflammation
|
Non-Steroidal Anti-Inflammatory Drugs (NSAID)
|
Non-Specific Cyclooxygenase Inhibitors (COX Inhibitors)
Products:
|
Toxicology
|
Heavy Metal Poisoning
|
Chelating Agents
|
Iron
Products:
|
Substance Abuse
|
Withdrawal
|
Alcohol
|
Gamma-Aminobutyric Acid (GABA) Receptor Agonists
Products:
|
Opioid Antagonists
Products:
|
Narcotics
|
Opioid Antagonists
Products:
|
Transplantation
|
Heart
|
Rejection Prophylaxis
|
Immunosuppressants
Products:
|
Hepatic (Liver)
|
Rejection Prophylaxis
|
Immunosuppressants
Products:
|
Renal (Kidney)
|
Rejection Prophylaxis
|
Immunosuppressants
Products:
|
Urology
|
Male Genital Disorders
|
Prostate
|
Benign Prostate Hyperplasia (BPH)
|
5-Alpha Reductase Inhibitors
Products:
|
Alpha Adrenergic Receptor Blocking Agents (Alpha Blockers)
Products:
|
Urological Disorders
|
Bladder
|
Neurogenic Bladder Disease
|
Anticholinergic Agents
Products:
|
Cholinergic Agents
Products:
|
Urinary Frequency/Urge Incontinence
|
Anticholinergic Agents
Products:
|
Kidney (Renal)
|
Chronic Renal Failure (CRF)
|
Complications
|
Edema
|
Loop Diuretic Agents
Products:
|
Potassium Sparing Diuretic Agents/Thiazide Diuretic Agents
Products:
|
Hyperparathyroidism
|
Calcimimetic Agents
Products:
|
Weight Management
|
Anorexia (Appetite Loss)
|
Progestins
Products:
|
Cachexia
|
Anabolic Testosterone Analogs
Products:
|
Progestins
Products:
|
Medical Devices
|
Clinical Diagnostics
|
Chemistry
|
Point of Care Testing
|
Kits
|
Fertility/Reproduction
Products:
|
General Surgery
|
Invasive
|
Transplantation
|
Organ Preservation
Products:
|
Obstetrics/Gynecology
|
Treatment
|
Procedure Specific
|
Contraception
|
Intrauterine Devices (IUD)
Products:
|
Key Financials
| Period Length/End |
3 months ending 09/30/2008 |
3 months ending 06/30/2008 |
3 months ending 09/30/2007 |
12 months ending 12/31/2007 |
6 months ending 12/31/2006 |
12 months ending 06/30/2006 |
| Total Revenue | 737.0 | 779.0 | 602.0 | 2,500.6 | 904.8 | 1,314.5 |
Gross Margin %
|
53.6 | 54.69 | 55.65 | 53.17 | 59.18 | 71.25 |
Operating Income
|
92.0 | 124.0 | 82.0 | 312.6 | -211.0 | 487.4 |
Operating Margin %
|
12.48 | 15.92 | 13.62 | 12.5 | -23.32 | 37.08 |
| Tax Rate % | 43.33 | 46.15 | 25 | 31.06 | -11.45 | 35.66 |
| Income After Taxes | 34.0 | 56.0 | 45.0 | 143.3 | -337.0 | 336.5 |
| Net Income Margin % | 4.61 | 7.19 | 7.48 | 5.73 | -37.25 | 25.6 |
F.D. EPS - Incl. Xord. Items
|
0.28 | 0.52 | 0.36 | 1.18 | -3.18 | 3.12 |
| Book Value Per Share | 18.91 | 19.93 | 16.30 | 17.31 | 13.75 | 15.92 |
Ratios
P/R Ratio (TTM)
|
2.63 |
P/E Ratio (TTM)
|
51.09 |
| Price To Free Cash Flow (TTM) | 30.07 |
| Price To Book Value | 3.49 |
| Net Assets to Market Cap. % | 42.60% |
| Beta | 0.29 |
Days to Sell Inventory
|
114.68 |
Current Ratio
|
2.64 |
Quick Ratio
|
1.82 |
| Interest Coverage | n/a |
| Debt to Market Cap. % | 23.39% |
| Return on Equity % | 7.3 |
| Return on Assets % | 3.17 |
| Return on Invested Capital % | 5.34 |
Major Competitors
| Name | Trailing Revenue | P/R Ratio (TTM) | P/E Ratio (TTM) | 1 Year Return % | Overlap |
|---|---|---|---|---|---|
Actavis Group hf.
|
n/a | n/a | n/a | n/a | 0 |
Bayer AG (ADR)
|
45,709.2 | 0.92 | 5.82 | -36.58% | 20 |
Dr. Reddy's Laboratories Limited (ADR)
|
1,105.3 | 1.56 | 19.76 | -41.09% | 58 |
Gedeon Richter Limited
|
n/a | n/a | n/a | n/a | 0 |
Johnson & Johnson
|
64,522.0 | 2.53 | 12.95 | -12.60% | 43 |
Mylan Inc.
|
5,089.8 | 0.58 | n/a | -29.77% | 137 |
Novartis AG (ADR)
|
42,407.0 | 2.49 | 13.99 | -13.46% | 135 |
Ranbaxy Laboratories Ltd.
|
n/a | n/a | n/a | n/a | 0 |
Ratiopharm GmbH
|
n/a | n/a | n/a | n/a | 0 |
Teva Pharmaceutical Industries Ltd (ADR)
|
10,813.0 | 3.28 | 18.76 | -1.20% | 162 |
Warner Chilcott Ltd.
|
923.3 | 3.80 | 27.60 | -20.79% | 9 |
Watson Pharmaceuticals, Inc.
|
2,517.6 | 1.01 | 11.58 | -10.72% | 104 |
Wyeth
|
23,249.1 | 2.13 | 11.06 | -19.82% | 38 |
| Average | 21,815.2 | 2.03 | 15.19 | -20.67% | 54 |
Notes:
- The company competes with other pharmaceutical companies.
Customers
| Name | Last Quarter Financial Stats | 1 YR Price Performance % | |||
|---|---|---|---|---|---|
| Y/Y Revenue Growth % | Sequential Revenue Growth % | Y/Y Margin Growth % | Sequential Margin Growth % | ||
Abbott Laboratories
|
17.58 | 2.51 | 28.19 | -3.15 | -8.67% |
AmerisourceBergen Corp.
|
5.31 | -4.66 | 8.76 | 7.63 | -20.48% |
CVS Caremark Corporation
|
1.80 | -1.31 | 13.31 | 0.51 | -31.73% |
Cardinal Health, Inc.
|
10.80 | 6.20 | -21.45 | -25.07 | -43.21% |
Government - United States
|
n/a | n/a | n/a | n/a | n/a |
McKesson Corporation
|
8.69 | -0.49 | -2.35 | 3.20 | -41.52% |
Shire Plc. (ADR)
|
27.91 | 0.39 | 325.14 | n/a | -33.79% |
Walgreen Company
|
8.76 | -2.79 | 8.36 | -19.94 | -28.31% |
| Average | 11.55 | -0.02 | 51.42 | -6.14 | -29.67% |
Notes:
- The company develops, manufactures and markets both generic & proprietary pharmaceutical products. Its customers include drug store chains, supermarket chains, mass merchandisers, wholesalers, distributors, managed care organizations, mail order accounts, government/military and repackagers.
Strategic Partners
| Name | Subtypes | 1 YR Price Performance % |
|---|---|---|
Abbott Laboratories
|
Marketing, Out-licensing | -8.67% |
Bayer AG (ADR)
|
In-licensing, Supplier | -36.58% |
Cephalon, Inc.
|
In-licensing, Supplier | 4.87% |
Savient Pharmaceuticals, Inc.
|
In-licensing, Supplier | -78.17% |
Shire Plc. (ADR)
|
Out-licensing, Research Collaboration | -33.79% |
Teva Pharmaceutical Industries Ltd (ADR)
|
In-licensing, Supplier | -1.20% |
Business/Geographical Segments
Business Segments
| External Revenue | Total Revenue | Gross Profit | Gross Margin (%) | ||||
|---|---|---|---|---|---|---|---|
| Generic | 562.0 | 76.3% | 562.0 | 76.3% | 258.0 | 65.3% | 45.91% |
| Proprietary | 133.0 | 18.0% | 133.0 | 18.0% | 101.0 | 25.6% | 75.94% |
| Other | 42.0 | 5.7% | 42.0 | 5.7% | 36.0 | 9.1% | 85.71% |
| Segment Total | 737.0 | 100.0% | 737.0 | 100.0% | 395.0 | 100.0% | 53.60% |
| Consolidated Total | 737.0 | 737.0 | 395.0 | 53.60% | |||
Actavis Group hf.